DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zarontin (Ethosuximide) - Published Studies

 
 



Zarontin Related Published Studies

Well-designed clinical trials related to Zarontin (Ethosuximide)

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. [2010.03.04]

Well-designed clinical trials possibly related to Zarontin (Ethosuximide)

Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy. [2013]

Other research related to Zarontin (Ethosuximide)

Effect of intracranial administration of ethosuximide in rats with spontaneous or pentylenetetrazol-induced spike-wave discharges. [2011.07]

Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy. [2010.08]

Ethosuximide converts ictogenic neurons initiating absence seizures into normal neurons in a genetic model. [2009.07]

Interactions of tiagabine with ethosuximide in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis for non-parallel dose-response relationship curves. [2008.11]

Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy. [2008.08]

Is ethosuximide a risk factor for generalised tonic-clonic seizures in absence epilepsy? [2007.04]

Characterization of the anticonvulsant, behavioral and pharmacokinetic interaction profiles of stiripentol in combination with clonazepam, ethosuximide, phenobarbital, and valproate using isobolographic analysis. [2006.11]

Evaluation of gabapentin and ethosuximide for treatment of acute nonconvulsive seizures following ischemic brain injury in rats. [2006.09]

7-Nitroindazole enhances dose-dependently the anticonvulsant activities of conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. [2006.09]

The effects of ethosuximide on amino acids in genetic absence epilepsy rat model. [2006.03]

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. [2005.10.19]

A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine. [2005.03]

Other possibly related research studies

Involvement of dorsolateral periaqueductal gray N-methyl-D-aspartic acid glutamate receptors in the regulation of risk assessment and inhibitory avoidance behaviors in the rat elevated T-maze. [2006.11]

Levetiracetam-induced myoclonic status epilepticus in myoclonic-astatic epilepsy: a case report. [2006.09]

Effects of anticonvulsant drugs on life span. [2006.04]

Influence of cimetidine on the anticonvulsant activity of conventional antiepileptic drugs against pentetrazole-induced seizures in mice. [2006.01]

Pharmacologic evidence for abnormal thalamocortical functioning in GABA receptor beta3 subunit-deficient mice, a model of Angelman syndrome. [2005.12]

Motor impairment on awakening in a patient with an EEG pattern of "unilateral, continuous spikes and waves during slow sleep". [2005.06]

Development of a new genetic model for absence epilepsy: spike-wave seizures in C3H/He and backcross mice. [2005.03.30]

Anticonvulsant medications extend worm life-span. [2005.01.14]

A magnetoencephalographic study of negative myoclonus in a patient with atypical benign partial epilepsy. [2005.01]

Epilepsy with myoclonic absences. [2006]

Differences between prescribed daily doses and defined daily doses of antiepileptics--therapeutic drug monitoring as a marker of the quality of the treatment. [2006.09]

Diagnostic issues and treatment of cryptogenic or symptomatic generalized epilepsies. [2006.08]

Role of valproate across the ages. Treatment of epilepsy in children. [2006]

[Carbamazepine-induced systemic lupus erythematosus--a case report] [2006.03]

Treatment of pediatric epilepsy: expert opinion, 2005. [2005.12]

Valproate as a mainstay of therapy for pediatric epilepsy. [2006]

Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents. [2006.03]

Treatment of epilepsy with electrical status epilepticus during slow sleep and its related disorders. [2006.06]

Management of Landau-Kleffner syndrome. [2005]

Evidence-based treatment of idiopathic generalized epilepsies with older antiepileptic drugs. [2005]

Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies. [2005]

Best practice guidelines for the management of women with epilepsy. [2005]

Photosensitivity in idiopathic generalized epilepsies. [2005]

Seizure control and acceptance of the ketogenic diet in GLUT1 deficiency syndrome: a 2- to 5-year follow-up of 15 children enrolled prospectively. [2005.10]

Anticonvulsant and neuroprotective effects of the novel nootropic agent nefiracetam on kainic acid-induced seizures in rats. [2005.09.28]

Antiepileptic drug monotherapy: pediatric concerns. [2005.06]

Treatment of epilepsy in adults: expert opinion, 2005. [2005.09]

Ion channels and epilepsy. [2005]

Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats. [2005.06]

Bupropion-induced convulsions: preclinical evaluation of antiepileptic drugs. [2005.03]

Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats. [2005.06]

Epilepsy with myoclonic absences. [2005.04]

Effect of antiepileptic drug polytherapy on crystalluria. [2005.02]

Mechanisms of action of antiepileptic drugs. [2005]

Sleep-related epilepsy in the A/J mouse. [2007.02.01]

7-12 Hz high-voltage rhythmic spike discharges in rats evaluated by antiepileptic drugs and flicker stimulation. [2007.01]

Prophylactic and therapeutic functions of T-type calcium blockers against noise-induced hearing loss. [2007.04]

Evaluation of anticonvulsant and analgesic effects of benzyl- and benzhydryl ureides. [2007.03.22]

Effect of antiepileptic drugs on spontaneous seizures in epileptic rats. [2007.02]

Juvenile myoclonic epilepsy: a benign disorder? Personality traits and psychiatric symptoms. [2007.06]

Negative myoclonus. An overview of its clinical features, pathophysiological mechanisms, and management. [2006.09]

Conventional anticonvulsant drugs in the guinea-pig kindling model of partial seizures: effects of repeated administration. [2007.03]

Current treatment of myoclonic astatic epilepsy: clinical experience at the Children's Hospital of Philadelphia. [2007.09]

Levetiracetam attenuates spontaneous spike-and-wave discharges in DBA/2J mice. [2007.07]

Beneficial effects of antiepileptic medication on absence seizures and cognitive functioning in children. [2007.08]

Effects of certain antiepileptics on behavioral and electromyographic seizure patterns induced by maximal electroshock in mice. [2007.05]

Thalidomide inhibits pentylenetetrazole-induced seizures. [2007.07.15]

Negative effects of antiepileptic drugs on mood in patients with epilepsy. [2007]

Antiepileptic drugs and visual function. [2007.06]

Treatment of pediatric epilepsy: European expert opinion, 2007. [2007.12]

Analysis and mapping of CACNB4, CHRNA1, KCNJ3, SCN2A and SPG4, physiological candidate genes for porcine congenital progressive ataxia and spastic paresis. [2007.10]

T-current related effects of antiepileptic drugs and a Ca2+ channel antagonist on thalamic relay and local circuit interneurons in a rat model of absence epilepsy. [2007.09]

Absence epilepsy in childhood: electroencephalography (EEG) does not predict outcome. [2007.07]

Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice. [2007.10]

Childhood absence epilepsy with clinically apparent genetic and acquired burdens: a diagnostic consideration. [2008.01]

Effects of various antiepileptics on behavioral and electroencephalographic seizures induced by maximal electroshock in mice. [2008.01]

Inhibition of human aromatase complex (CYP19) by antiepileptic drugs. [2008.02]

Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety. [2007.10]

Early treatment suppresses the development of spike-wave epilepsy in a rat model. [2008.03]

Drug interactions between chemotherapeutic regimens and antiepileptics. [2008.08]

Epileptogenic activity induced by teicoplanin and effects of some antiepileptics in mice. [2008.08]

The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models. [2008.07]

Antiepileptic drug therapy in pregnancy II: fetal and neonatal exposure. [2008]

Use of a new antiepileptic drug or an old one as first drug for treatment of absence epilepsy. [2009.09]

Rational treatment options with AEDs and ketogenic diet in Landau-Kleffner syndrome: still waiting after all these years. [2009.08]

Absence seizures: a review of recent reports with new concepts. [2009.08]

Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions. [2009.03]

Managing epilepsy in women of childbearing age. [2009]

Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959-2009. [2009.03]

Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy. [2009.02]

Clinical spectrum and medical treatment of children with electrical status epilepticus in sleep (ESES). [2009.06]

Television-provoked epilepsy in children: a follow-up survey from Isfahan, Iran. [2008.11]

[Specific language impairment and electroencephalogram: which recommendations in clinical practice? A cohort of 24 children] [2010.04]

New antiepileptic drugs: molecular targets. [2009.06]

Intra-periaqueductal grey microinjections of an imidazo[1,2-b]pyridazine derivative, DM2, affects rostral ventromedial medulla cell activity and shows antinociceptive effect. [2010.03]

Impact of antiepileptic drugs on cognition, behavior, and motor skills in children with new-onset, idiopathic epilepsy. [2009.10]

A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs. [2009.11.03]

Acceleration of pentylenetetrazol seizure kindling associated with induction of sensitized visual responses evoked by strobe stimulation. [2009.10.06]

Pharmacodynamic interactions between antiepileptic drugs: preclinical data based on isobolography. [2009.02]

Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model. [2011.07]

Epilepsy with myoclonic absences - favourable response to add-on rufinamide treatment in 3 cases. [2011.02]

Synthesis and anticonvulsant activity of new n-mannich bases derived from 5-cyclopropyl-5-phenyl-hydantoins. [2011.04]

Detection of nonlinear interactions of EEG alpha waves in the brain by a new coherence measure and its application to epilepsy and anti-epileptic drug therapy. [2011.04]

Orphenadrine induces secondarily generalized convulsive status epilepticus in rats. [2011.04.05]

Long term outcome in children affected by absence epilepsy with onset before the age of three years. [2011.02]

Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis. [2011.01]

Disrupted thalamic T-type Ca2+ channel expression and function during ethanol exposure and withdrawal. [2011.02]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014